Paul Verhezen

520 citations

22 papers · 329 indexed · h-index 11

Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management 6
Critical Care and Intensive Care Medicine top 10%
- Trauma, Hemostasis, Coagulopathy, Resuscitation 4
Hematology top 10%
- Platelet Disorders and Treatments 7
Cardiology and Cardiovascular Medicine
- Antiplatelet Therapy and Cardiovascular Diseases 9
- Atrial Fibrillation Management and Outcomes 5
Biochemistry
- Blood transfusion and management 2
Pulmonary and Respiratory Medicine
- Blood properties and coagulation 5
Surgery
- Muscle and Compartmental Disorders 2

Co-authors: Yvonne Henskens Rick J. H. Wetzels Hugo Ten Cate Minka J. A. Vries Erik A.M. Beckers Renske H. Olie René van Oerle Henri M.H. Spronk
Cited by: Internal Medicine Critical Care and Intensive Care Medicine Hematology
Journals: SHILAP Revista de lepidopterología (1 paper)Blood (1 paper)PLoS ONE (1 paper)
Partner nations: Netherlands United Kingdom United States

In The Last Decade

Paul Verhezen

21 papers receiving 322 citations

Peers

Countries citing papers authored by Paul Verhezen

Since Specialization

Citations

This map shows the geographic impact of Paul Verhezen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Verhezen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Verhezen more than expected).

Fields of papers citing papers by Paul Verhezen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Verhezen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Verhezen. The network helps show where Paul Verhezen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Paul Verhezen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul Verhezen Line = papers co-authored together Paul Verhezen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Heterophilic antibodies leading to falsely positive D-dimer concentration in an adolescent Research and Practice in Thrombosis and Haemostasis ·Daniëlle R. J. Verboogen,Bernd Granzen,Francisca Hudig,Daan van de Kerkhof,Paul Verhezen,Douwe de Boer,Yvonne Henskens	2023	2
2	Fibrinolysis Assessment with Tpa-ROTEM in Patients with Bleeding Disorders of Unknown Cause (BDUC) Blood ·Amaury Monard,Yvonne Henskens,Paul Verhezen,Dave Hellenbrand,Erik A.M. Beckers,Floor CJI Moenen	2023	0
3	Multiparameter platelet function analysis of bleeding patients with a prolonged platelet function analyser closure time British Journal of Haematology ·Floor Heubel-Moenen,Sanne L. N. Brouns,Linda Herfs,Lara S. Boerenkamp,Natalie J. Jooss,Rick J. H. Wetzels,Paul Verhezen,Patric Machiels,Karyn Mégy,Kate Downes,Johan W. M. Heemskerk,Erik A.M. Beckers,Yvonne Henskens	2022	8
4	Effectiveness and costs of a stepwise versus an all‐in‐one approach to diagnose mild bleeding disorders British Journal of Haematology ·Floor Heubel-Moenen,Loes E. M. Ansems,Paul Verhezen,Rick J. H. Wetzels,Rene G. M. van Oerle,Ron J. M. H. E. Straat,Karyn Mégy,Kate Downes,Yvonne Henskens,Erik A.M. Beckers,Manuela Joore	2022	2
5	Assessment of need for hemostatic evaluation in patients taking valproic acid: A retrospective cross-sectional study PLoS ONE ·Demi S. Post,Arian van der Veer,Olaf Schijns,Sylvia Klinkenberg,Kim Rijkers,G Wagner,Vivianne H.J.M. van Kranen‐Mastenbroek,Paul Willems,Paul Verhezen,Erik A.M. Beckers,Floor Heubel-Moenen,Yvonne Henskens	2022	11
6	Serial EXTEM, FIBTEM, and tPA Rotational Thromboelastometry Observations in the Maastricht Intensive Care COVID Cohort—Persistence of Hypercoagulability and Hypofibrinolysis Despite Anticoagulation Frontiers in Cardiovascular Medicine ·Anne‐Marije Hulshof,Renée A. G. Brüggemann,Mark M. G. Mulder,Tom W. van de Berg,Jan-Willem E. M. Sels,Renske H. Olie,Bart Spaetgens,Alexander S. Streng,Paul Verhezen,Iwan C.C. van der Horst,Hugo Ten Cate,Henri M.H. Spronk,Bas C. T. van Bussel,Yvonne Henskens	2021	36
7	Determining the optimal storage time and temperature for performing platelet function assays and global hemostasis assays Platelets ·Ellen J S Denessen,Danique L. van den Kerkhof,Mike L. J. Jeurissen,Rick J. H. Wetzels,Paul Verhezen,Yvonne Henskens	2021	2
8	Rotational Thromboelastometry in High-Risk Patients on Dual Antithrombotic Therapy After Percutaneous Coronary Intervention Frontiers in Cardiovascular Medicine ·Anne‐Marije Hulshof,Renske H. Olie,Minka J. A. Vries,Paul Verhezen,Paola E. J. van der Meijden,Hugo Ten Cate,Yvonne Henskens	2021	2
9	Determining the maximal storage time of centrifuged citrated samples for performing add-on routine coagulation tests Thrombosis Research ·Ellen J S Denessen,Mike L. J. Jeurissen,R.M.T.A. Pereboom,Paul Verhezen,Yvonne Henskens	2020	5
10	Monitoring of Unfractionated Heparin in Severe COVID-19: An Observational Study of Patients on CRRT and ECMO SHILAP Revista de lepidopterología ·Alexander S. Streng,Thijs Delnoij,Mark M. G. Mulder,Jan Willem Sels,Rick J. H. Wetzels,Paul Verhezen,Renske H. Olie,Jeroen P. Kooman,Sander M. J. van Kuijk,Lloyd Brandts,Hugo Ten Cate,Roberto Lorusso,Iwan C.C. van der Horst,Bas C. T. van Bussel,Yvonne Henskens	2020	29
11	Harmonizing light transmission aggregometry in the Netherlands by implementation of the SSC-ISTH guideline Platelets ·Imke C.A. Munnix,René van Oerle,Paul Verhezen,P. H. M. Kuijper,C. M. Hackeng,H.I.J. Hopman-Kerkhoff,Francisca Hudig,Daan van de Kerkhof,Anja Leyte,Moniek P.M. de Maat,Rob F. M. Oude Elferink,Janneke Ruinemans‐Koerts,Marianne Schoorl,Jennichjen Slomp,Hans Soons,An K. Stroobants,Eduard van Wijk,Yvonne Henskens	2020	14
12	Fibrinolysis in patients with chemotherapy‐induced thrombocytopenia and the effect of platelet transfusion Journal of Thrombosis and Haemostasis ·Floor Heubel-Moenen,Yvonne Henskens,Paul Verhezen,Rick J. H. Wetzels,Harry C. Schouten,Erik A.M. Beckers	2019	9
13	New membranes based on polyethersulfone – SlipSkin™ polymer blends with low fouling and high blood compatibility Separation and Purification Technology ·O. ter Beek,Denys Pavlenko,Meina Suck,S. Helfrich,Lydia A.M. Bolhuis‐Versteeg,D. Snisarenko,Christel Causserand,Patrice Bacchin,Pierre Aimar,René van Oerle,Rick J. H. Wetzels,Paul Verhezen,Yvonne Henskens,Dimitrios Stamatialis	2019	29
14	Detecting clinically relevant rivaroxaban or dabigatran levels by routine coagulation tests or thromboelastography in a cohort of patients with atrial fibrillation Thrombosis Journal ·Yvonne Henskens,Anouk J. W. Gulpen,René van Oerle,Rick J. H. Wetzels,Paul Verhezen,Henri M.H. Spronk,Simon Schalla,Harry J.G.M. Crijns,Hugo Ten Cate,Arina J. ten Cate‐Hoek	2018	40
15	Assessment and determinants of whole blood and plasma fibrinolysis in patients with mild bleeding symptoms Thrombosis Research ·Minka J. A. Vries,Fraser L. Macrae,Patricia J. Nelemans,Gerhardus J.A.J.M. Kuiper,Rick J. H. Wetzels,Polly Bowman,Paul Verhezen,Hugo Ten Cate,Robert A.S. Ariëns,Yvonne Henskens	2018	7
16	Platelet Aggregation in Healthy Participants is Not Affected by Smoking, Drinking Coffee, Consuming a High-Fat Meal, or Performing Physical Exercise Clinical and Applied Thrombosis/Hemostasis ·Joyce P.M. Krekels,Paul Verhezen,Yvonne Henskens	2018	10
17	The use of regression analysis in determining reference intervals for low hematocrit and thrombocyte count in multiple electrode aggregometry and platelet function analyzer 100 testing of platelet function Platelets ·Gerhardus J.A.J.M. Kuiper,Rik Houben,Rick J. H. Wetzels,Paul Verhezen,René van Oerle,Hugo Ten Cate,Yvonne Henskens,Marcus D. Lancé	2017	16
18	Screening for platelet function disorders with Multiplate and platelet function analyzer Platelets ·Floor CJI Moenen,Minka J. A. Vries,Patricia J. Nelemans,Katrien J. M. van Rooy,Jeannique R. R. A. Vranken,Paul Verhezen,Rick J. H. Wetzels,Hugo Ten Cate,Harry C. Schouten,Erik A.M. Beckers,Yvonne Henskens	2017	47
19	Determinants of agreement between proposed therapeutic windows of platelet function tests in vulnerable patients European Heart Journal - Cardiovascular Pharmacotherapy ·Minka J. A. Vries,Heleen Bouman,Renske H. Olie,Leo Veenstra,Suzanne Zwaveling,Paul Verhezen,Arina J. ten Cate‐Hoek,Hugo Ten Cate,Yvonne Henskens,Paola E. J. van der Meijden	2016	22
20	Early platelet recovery following cardiac surgery with cardiopulmonary bypass Platelets ·Sven Van Poucke,Kris Stevens,Rick J. H. Wetzels,Cécile Kicken,Paul Verhezen,Maurice Theunissen,Gerhardus J.A.J.M. Kuiper,René van Oerle,Yvonne Henskens,Marcus D. Lancé	2016	24

About Paul Verhezen

Paul Verhezen is a scholar working on Internal Medicine, Hematology and Critical Care and Intensive Care Medicine, having authored 22 papers that have together received 329 indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (9 papers), Platelet Disorders and Treatments (7 papers), Venous Thromboembolism Diagnosis and Management (6 papers), Blood properties and coagulation (5 papers), Atrial Fibrillation Management and Outcomes (5 papers), Trauma, Hemostasis, Coagulopathy, Resuscitation (4 papers), Muscle and Compartmental Disorders (2 papers) and Blood transfusion and management (2 papers). The work is most often cited by research in Internal Medicine (94 citations), Critical Care and Intensive Care Medicine (48 citations) and Hematology (94 citations). Paul Verhezen has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Yvonne Henskens, Rick J. H. Wetzels, Hugo Ten Cate, Minka J. A. Vries, Erik A.M. Beckers, Renske H. Olie, René van Oerle, Henri M.H. Spronk, Harry C. Schouten and Arina J. ten Cate‐Hoek. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact